Vanishing white matter disease: a case of combined saposin deficiency
DOI:
https://doi.org/10.18203/2349-3291.ijcp20231506Keywords:
Ataxia, Developmental delay, EIF2B gene mutations, White matter disorders, LeukoencephalopathyAbstract
Vanishing white matter disease (VWMD) is an autosomal recessive neurodegenerative disease often present during childhood and is exacerbated by trauma and other stressors. VWMD is caused by EIF2B gene mutation, which encodes eukaryotic initiation factor 2 B (EIF2B), a transcription factor activated by insulin that is a major protein synthesis regulator during the integrated stress response. Autosomal recessive combined saposin deficiency is a metachromatic leukodystrophy, a progressive neurological disorder characterized by motor delay, regression of gained skills, and nerve demyelination. Here, we present the case of an 11-year-old Hispanic male presenting with ataxia, dysphagia, and global developmental delay which was found to have VWMD on imaging. A genetic panel reveals the PSAP gene, a novel presentation in the setting of VWMD.
Metrics
References
Knaap MS, Breiter SN, Naidu S, Hart AA, Valk J. Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology. 1999;213(1):121-33.
Knaap MS, Pronk JC, Scheper GC. Vanishing white matter disease. Lancet Neurol. 2006;5(5):413-23.
Vinogradsky EI, Otallah SI. Vanishing White Matter Disease Diagnosis After Athletic Concussion in an Adolescent Male Patient. Clin J Sport Med. 2021;31(4):207-9.
Pronk JC, Kollenburg B, Scheper GC, Knaap MS. Vanishing white matter disease: a review with focus on its genetics. Ment Retard Dev Disabil Res Rev. 2006;12(2):123-8.
Viñas E, Pineda M, Cusí V, López-Laso E, Del Pozo RL, Gutiérrez-Solana LG, et al. Vanishing white matter disease in a spanish population. J Cent Nerv Syst Dis. 2014;6:59-68.
Boone M, Wang L, Lawrence RE, Frost A, Walter P, Schoof M. A point mutation in the nucleotide exchange factor eIF2B constitutively activates the integrated stress response by allosteric modulation. Elife. 2022;11:e76171.
Knaap MS, Leegwater PA, Könst AA, Visser A, Naidu S, Oudejans CB, et al. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol. 2002;51(2):264-70.
Leegwater PA, Pronk JC, Knaap MS. Leukoencephalopathy with vanishing white matter: from magnetic resonance imaging pattern to five genes. J Child Neurol. 2003;18(9):639-45.
Knaap MS, Barth PG, Gabreëls FJ, Franzoni E, Begeer JH, Stroink H, et al. A new leukoencephalopathy with vanishing white matter. Neurology. 1997;48(4):845-55.
Knaap MS, Berkel CG, Herms J, Coster R, Baethmann M, Naidu S, et al. eIF2B-related disorders: antenatal onset and involvement of multiple organs. Am J Hum Genet. 2003;73(5):1199-207.
Eicke W. Polycystic transformation of the medulla with progressive course. Atypical diff use sclerosis? Arch Psychiatrist Nerve Cr. 1962;203:4.
Stellingwerff MD, Al-Saady ML, Brug T, Barkhof F, Pouwels PJW, Knaap MS. MRI Natural History of the Leukodystrophy Vanishing White Matter. Radiology. 2021;300(3):671-80.
Knaap MS, Wevers RA, Kure S, Gabreëls FJ, Verhoeven NM, Raaij-Selten B, et alJ. Increased cerebrospinal fluid glycine: a biochemical marker for a leukoencephalopathy with vanishing white matter. J Child Neurol. 1999;14(11):728-31.
Sugiura C, Miyata H, Oka A, Takashima S, Ohama E, Takeshita K. A Japanese girl with leukoencephalopathy with vanishing white matter. Brain Dev. 2001;23(1):58-61.
Vanderver A, Schiffmann R, Timmons M, Kellersberger KA, Fabris D, Hoffman EP, et al. Decreased asialotransferrin in cerebrospinal fluid of patients with childhood-onset ataxia and central nervous system hypomyelination/vanishing white matter disease. Clin Chem. 2005;51(11):2031-42.
Alamri H, Al Mutairi F, Alothman J, Alothaim A, Alfadhel M, Alfares A. Diabetic ketoacidosis in vanishing white matter. Clin Case Rep. 2016;4(8):717-20.
Campbell LE, Wang X, Proud CG. Nutrients differentially regulate multiple translation factors and their control by insulin. Biochem J. 1999;344 Pt 2(Pt 2):433-41.
Herrero M, Daw M, Atzmon A, Elroy-Stein O. The Energy Status of Astrocytes Is the Achilles' Heel of eIF2B-Leukodystrophy. Cells. 2021;10(8):1858.
Foll C, Levin BE. Fatty acid-induced astrocyte ketone production and the control of food intake. Am J Physiol Regul Integr Comp Physiol. 2016;310(11):1186-92.
Lemieux G, Pichette C, Vinay P, Gougoux A. Cellular mechanisms of the antiammoniagenic effect of ketone bodies in the dog. Am J Physiol. 1980;239(5):F420-6.
Johns Hopkins University. Online Mendelian Inheritance in Man, OMIM®. Combined saposin deficiency, 2020. Available at: https://www.omim. org/entry/611721. Accessed on 22 April 2023.
Motta M, Tatti M, Furlan F, Celato A, Di Fruscio G, Polo G, et al. Clinical, biochemical and molecular characterization of prosaposin deficiency. Clin Genet. 2016;90(3):220-9.
Harzer K, Paton BC, Poulos A, Kustermann-Kuhn B, Roggendorf W, Grisar T, et al. Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses. Eur J Pediatr. 1989;149(1):31-9.
Bhat V, Thergaonkar RW, Thakur M, Rajkamal T. Combined saposin deficiency: A rare occurrence. Med J Armed Forces India. 2023;79(2):238-40.
Hulková H, Cervenková M, Ledvinová J, Tochácková M, Hrebícek M, Poupetová H, et al. A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation. Hum Mol Genet. 2001;10(9):927-40.
Sikora J, Harzer K, Elleder M. Neurolysosomal pathology in human prosaposin deficiency suggests essential neurotrophic function of prosaposin. Acta Neuropathol. 2007;113(2):163-75.
Hillen AEJ, Hruzova M, Rothgangl T, Breur M, Bugiani M, van der Knaap MS, Schwank G, Heine VM. In vivo targeting of a variant causing vanishing white matter using CRISPR/Cas9. Mol Ther Methods Clin Dev. 2022;25:17-25.
Downloads
Published
How to Cite
Issue
Section
